Gland Pharma gains FDA approval for Edaravone Injection, set to treat ALS
Gland Pharma Limited, a prominent player in the generic injectable-focused pharmaceutical industry, has received approval from the United States Food and Drug Administration (USFDA) for its Edaravone Injection. This approval marks a significant milestone for the company as it prepares to offer new therapeutic options for patients suffering from amyotrophic lateral sclerosis (ALS). Product Details […]